Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chimeric restriction enzymes: what is next?

S Chandrasegaran1, J Smith

  • 1Department of Environmental Health Sciences, School of Public Health, The Johns Hopkins University, Baltimore, MD 21205, USA.

Biological Chemistry
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rate of death from cervical cancer among native Indian women in British Columbia.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1992
Same author

Screening for neuroblastoma in the north of England.

BMJ (Clinical research ed.)·1992
Same author

Comparison of doxycycline and a chemically modified tetracycline inhibition of leukocyte functions.

Research communications in chemical pathology and pharmacology·1992
Same author

Sequence of the gene encoding the mitochondrial capsule selenoprotein of mouse sperm: identification of three in-phase TGA selenocysteine codons.

DNA and cell biology·1992
Same author

Screening for neuroblastoma in the northern region of England. Laboratory aspects.

The American journal of pediatric hematology/oncology·1992
Same author

A pilot study of screening for neuroblastoma in the north of England.

The American journal of pediatric hematology/oncology·1992
Same journal

Neuronal membrane organization by the submembranous spectrin-ankyrin scaffold: evolution, specialization and disease.

Biological chemistry·2026
Same journal

Golgi-associated membrane scaffolds: roles in health and disease.

Biological chemistry·2026
Same journal

Mechanistic insights on spatiotemporal control of Ras-signaling.

Biological chemistry·2026
Same journal

Cysteine cathepsin proteases in apicomplexan parasites.

Biological chemistry·2026
Same journal

Electron donating and withdrawing groups affect the antioxidant activity of 4'-aminochalcones on gentamicin-induced kidney cell injury.

Biological chemistry·2026
Same journal

CNKSR2 scaffold function in the mammalian nervous system.

Biological chemistry·2026
See all related articles

Engineered chimeric restriction enzymes, like Zif-QQR-F(N), can precisely cut DNA targets in vivo. This breakthrough enables targeted genome engineering and holds promise for gene therapy applications.

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Genetics

Background:

  • Chimeric restriction enzymes combine DNA-binding motifs with the FokI cleavage domain.
  • Zinc finger DNA-binding proteins are key components due to their modularity.
  • Previous studies demonstrated in vitro specificity of these engineered nucleases.

Purpose of the Study:

  • To demonstrate the in vivo efficacy of chimeric nucleases.
  • To assess the potential of engineered nucleases for genome engineering.
  • To investigate the role of chimeric nucleases in homologous recombination.

Main Methods:

  • Microinjection of DNA substrates and the Zif-QQR-F(N) enzyme into frog oocytes.
  • Analysis of site-specific double-strand breaks in target DNA.

Related Experiment Videos

  • Evaluation of homologous recombination activation.

    • Main Results:

    • The Zif-QQR-F(N) enzyme successfully located and cleaved its target DNA in vivo.
    • Cleavage occurred site-specifically, even within assembled chromatin.
    • The induced DNA breaks efficiently activated homologous recombination.

    Conclusions:

    • Engineered chimeric nucleases, particularly zinc finger-based ones, are effective tools for in vivo genome targeting.
    • The ability to engineer specificity opens avenues for precise genome engineering and gene therapy.
    • This technology facilitates targeted DNA modification and subsequent genetic manipulation.